Veterinary access to legitimate xylazine must be preserved while combating the emerging public health threat of illicit xylazine. Xylazine is an essential drug used across veterinary medicine for the safe handling of many species.
Scheduling of xylazine without a provision for its unique needs in veterinary medicine will severely disrupt or eliminate the legitimate supply and prohibit critical uses of the drug.
Resource Type
- Document
Topic
- Medication
- Veterinary Practice
Publish Date
March 19, 2024
Related Resources
AAEP Position on Therapeutic Medication for the Competition Horse
The AAEP policy on medication in the competition horse is driven by…
Position on the Use of Medroxyprogesterone Acetate in Competition Horses
Medroxyprogesterone acetate (MPA) is a synthetic progestin hormone administered to mares off-label…
Position on the Use of Therapeutic Medication in the Racehorse
The AAEP policy on medication in pari-mutuel racing is driven by our…